BDBM801013 2-((2-((4-(1-((trans)-5-hydroxyadamantan-2-yl)piperidin-4-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)-3-methylbenzamide ::US12590070, Compound 34

SMILES COc1cc(C2CCN([C@H]3C4CC5CC3C[C@](O)(C5)C4)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2c(C)cccc2C(N)=O)n1

InChI Key InChIKey=RXINQGVYLPLTLP-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 801013   

TargetProtein-tyrosine kinase 2-beta(Human)
Samjin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 801013BDBM801013(2-((2-((4-(1-((trans)-5-hydroxyadamantan-2-yl)pipe...)
Affinity DataIC50: 427nMAssay Description:The inhibitory activity of the adamantane derivative compounds of the present invention to FAK, Pyk2 and InsR was confirmed through a biochemical kin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/10/2026
Entry Details
US Patent

TargetInsulin receptor(Human)
Samjin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 801013BDBM801013(2-((2-((4-(1-((trans)-5-hydroxyadamantan-2-yl)pipe...)
Affinity DataIC50: 1.64E+3nMAssay Description:The inhibitory activity of the adamantane derivative compounds of the present invention to FAK, Pyk2 and InsR was confirmed through a biochemical kin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/10/2026
Entry Details
US Patent